Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abasaglar KwikPen 100units/ml inj 3ml pre-filled pens
0601012V0BDACAD
|
Abasaglar | Insulin glargine | Endocrine System | 63,399 |
|
Abasaglar 100units/ml solution for injection 3ml cartridges
0601012V0BDABAA
|
Abasaglar | Insulin glargine | Endocrine System | 4,143 |
|
Abasaglar Tempo Pen 100units/ml inj 3ml pre-filled pens
0601012V0BDADAD
|
Abasaglar | Insulin glargine | Endocrine System | 30 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.